UnitedHealth Group’s Neutral Rating Reaffirmed at Zacks (UNH)
UnitedHealth Group (NYSE:UNH)‘s stock had its “neutral” rating reaffirmed by Zacks in a report released on Friday, StockRatingsNetwork.com reports. They currently have a $76.00 price target on the stock. Zacks‘ price target would suggest a potential upside of 4.44% from the company’s current price.
Zacks‘ analyst wrote, “UnitedHealth’s fourth-quarter 2013 earnings beat the Zacks Consensus Estimate by a penny and were up 17.5% year over year. UnitedHealth exhibited strong performance in 2013 despite facing headwinds on account of the Affordable Care Act, by increasing enrollment and expanding its markets internationally. We also praise UnitedHealth for following a differentiated growth strategy by building on its business from Optum, which offers higher margin contribution and also has potential to contribute to the company’s long-term growth. The company has also successfully maintained its medical cost ratio at levels within the Obamacare mandated range of 80-85%. However, medicare reimbursement cuts, industry fees and taxes, and higher operating costs are some of the near term headwinds facing the company. Nevertheless, the company’s capital strength and a niche market position are some of the positives it should benefit from. We thus maintain our Neutral recommendation on the stock. “
Other equities research analysts have also recently issued reports about the stock. Analysts at FBR Capital Markets raised their price target on shares of UnitedHealth Group from $77.00 to $85.00 in a research note to investors on Thursday. They now have an “outperform” rating on the stock. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of UnitedHealth Group in a research note to investors on Monday. Finally, analysts at Deutsche Bank upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note to investors on Tuesday, January 7th. They now have a $85.00 price target on the stock, up previously from $74.00. Six analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $79.22.
Shares of UnitedHealth Group (NYSE:UNH) traded down 0.11% on Friday, hitting $72.68. The stock had a trading volume of 2,666,190 shares. UnitedHealth Group has a 52-week low of $52.51 and a 52-week high of $77.33. The stock has a 50-day moving average of $73.75 and a 200-day moving average of $71.94. The company has a market cap of $73.171 billion and a P/E ratio of 13.76.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, January 15th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.01. The company had revenue of $31.10 billion for the quarter, compared to the consensus estimate of $31.06 billion. During the same quarter in the previous year, the company posted $1.20 earnings per share. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. Analysts expect that UnitedHealth Group will post $5.61 EPS for the current fiscal year.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.